Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...

Eli Lilly has today forecast annual profit largely above Wall Street estimates, providing some relief to investors after ...

The forecast comes weeks after the drugmaker stunned investors with weaker-than-expected sales for its weight-loss drug ...

Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Lilly's fourth-quarter earnings, released before the market opened Thursday, surpassed analysts' expectations by millions.

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...

Goldberg said the company "melded" a CBS News Sunday Mornings appearance from her to sell “bad weight loss drugs." ...

Whoopi Goldberg made it clear she had no involvement with the promotion of any kind of products and warned fans against ...

On Feb. 5’s episode of The View, host Whoopi Goldberg stopped the show from taking a commercial break to give a warning: she says there is an Instagram ad using an AI version of her likeness to sell ...